Data-Driven Innovation in Life and Health Insurance
RGA's Marc Sofer, Head of Data and Strategic Analytics, Asian Markets, discusses how the newest data sets, together with existing data and novel analytics, are impacting the industry’s growth and development.
Cannabody: The Insurer's Quick Reference Guide to Recreational Cannabis Use
Curious about the effects of recreational cannabis use on the human body? RGA South Africa produced a quick reference guide for insurers.
Don’t Share Your Health Data with Insurance Companies Just for the Perks
Insurers are today capable of and are, in fact, gathering ever-more-detailed information about us, using publicly available and purchasable information like shopping records, household details, and social-media profiles to inform decisions.
Underwriting and Claims: In Plain View - Interrupting Violence and Abuse
Our deepening understanding of physical costs of violence and abuse has profound implications for life and health insurance. RGA’s ROSEBUD® Consulting Group recently invited Pamela DeWitt-Meza to present a webinar on “Intersections of Abuse” to help case managers identify signs of abuse and intervene effectively, and she discusses the highlights in a brief interview.
Why Wearables are no Gimmick in the Quest for Wellness
It is well understood that increased physical activity levels are linked with a reduced risk of certain illnesses, leading to improved healthy life expectancy. Wearable devices have also been championed as a way to not only help people track physical activity, but with the right incentives, increase overall activity levels in the short term.
The Rising Tide of Genetic Data – New Challenges for Life & Health Insurance
The understanding and application of genetic data is redefining medical diagnosis, treatment and prognosis. As this area continues to advance, it’s set to adjust, maybe even to reshape, the Life and Health insurance business model within the next 20 years.
It’s Time to Future-Proof Your Data, Systems and Culture
The long-term prospects of most Life and Health insurers are going to be determined by their ability to transition from a product-based approach to a customer-centric value proposition. But, if they’re going to make that leap, insurers will have to know more about their customers, their behaviors and decision-making processes.
Predictive Analytics Global Survey Results - Still Room to Grow for Life & Health Insurers
How big is “big data” for life and health insurers? What are insurers worldwide focused on when it comes to predictive analytics? How are they adopting it and what are their expectations for the future? We set out to find answers to these questions through our global predictive analytics survey just released to participants this month.
Insurers Shouldn’t Stigmatize Epilepsy (Gen Re)
Epilepsy is a neurological disorder that can affect people of all ages. According to the WHO, some 50 million people around the world have epilepsy and an estimated 2.4 million new diagnoses are made each year. The condition has significant implications for life and health insurance because it is associated with loss of productivity, increased healthcare needs and even premature death.
Health Market Needs Medical Underwriting, Analyst Says
Merrill Matthews Jr., a health policy analyst, says one key to reviving the U.S. individual major medical market is bringing back medical underwriting.